Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens Jan 6, 2026 Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer Dec 18, 2025 Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic Oct 3, 2025 Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team Sep 3, 2025
Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens Jan 6, 2026
Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer Dec 18, 2025
Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic Oct 3, 2025
Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team Sep 3, 2025
